Previously, we reported the presence of a significantly larger number of leukocytes and nucleated cells of unknown origin after EpCAM enrichment in blood of NSCLC patients, compared to healthy donors [43]. This evidence concerns the gene EPCAM and non-small cell lung carcinoma.